neolymphostin A
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.1
|
pKd |
14 |
|
⤷ |
pKd
9.1
(Kd 8.8x10-10 M)
[14]
Description: Determined using an active-site dependent competition binding assay.
|
bimiralisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.8
|
pKd |
|
|
⤷ |
pKd
8.8
(Kd 1.5x10-9 M)
|
wortmannin
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.3
|
pKd |
14 |
|
⤷ |
pKd
8.3
(Kd 5.4x10-9 M)
[14]
|
eganelisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.8
|
pKd |
25 |
|
⤷ |
pKd
7.8
(Kd 1.7x10-8 M)
[25]
|
STX-478
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.2 – 8.3
|
pKd |
9 |
|
⤷ |
pKd
8.3
(Kd 4.7x10-9 M)
[9]
Description: Affinity for PI3Kα with the H1047R mutation
pKd
7.2
(Kd 7x10-8 M)
[9]
Description: Affinity for wild type PI3Kα
|
quinostatin
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.2
|
pKd |
83 |
|
⤷ |
pKd
6.2
(Kd 6x10-7 M)
[83]
Description: In vitro binding affinity to recombinant complex of PI3K alpha regulatory and catalytic subunits.
|
PQR620
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.0
|
pKd |
67 |
|
⤷ |
pKd
6.0
(Kd 1x10-6 M)
[67]
|
compound 12b [PMID: 31465220]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.8
|
pKd |
6 |
|
⤷ |
pKd
5.8
(Kd 1.6x10-6 M)
[6]
|
PF-06843195
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
>10.7
|
pKi |
17 |
|
⤷ |
pKi
>10.7
(Ki <1.8x10-11 M)
[17]
|
inavolisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
10.5
|
pKi |
7 |
|
⤷ |
pKi
10.5
(Ki 3.4x10-11 M)
[7]
|
taselisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.5 – 10.1
|
pKi |
7,59 |
|
⤷ |
pKi
10.1
(Ki 9x10-11 M)
[7]
pKi
9.5
(Ki 2.9x10-10 M)
[59]
|
PF-04691502
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.2
|
pKi |
52 |
|
⤷ |
pKi
9.2
(Ki 5.7x10-10 M)
[52]
|
compound 82 [PMID: 21332118]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.9
|
pKi |
22 |
|
⤷ |
pKi
8.9
(Ki 1.2x10-9 M)
[22]
|
pictilisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.6
|
pKi |
7 |
|
⤷ |
pKi
8.6
(Ki 2.56x10-9 M)
[7]
|
omipalisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.7
|
pKi |
47 |
|
⤷ |
pKi
7.7
(Ki 1.9x10-8 M)
[47]
|
wortmannin
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.9
|
pKi |
34 |
|
⤷ |
pKi
6.9
(Ki 1.2x10-7 M)
[34]
|
compound 22 [PMID: 24754609]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.9
|
pKi |
19 |
|
⤷ |
pKi
6.9
(Ki 1.32x10-7 M)
[19]
|
PQR620
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.4
|
pKi |
67 |
|
⤷ |
pKi
5.4
(Ki 4.203x10-6 M)
[67]
|
compound 15a [PMID: 32069401]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.7
|
pIC50 |
84 |
|
⤷ |
pIC50
9.7
(IC50 2x10-10 M)
[84]
|
vulolisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.7
|
pIC50 |
85 |
|
⤷ |
pIC50
9.7
(IC50 2x10-10 M)
[85]
|
gedatolisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.4
|
pIC50 |
75 |
|
⤷ |
pIC50
9.4
(IC50 4x10-10 M)
[75]
|
copanlisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.3
|
pIC50 |
53 |
|
⤷ |
pIC50
9.3
(IC50 5x10-10 M)
[53]
|
HS-173
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.1
|
pIC50 |
45 |
|
⤷ |
pIC50
9.1
(IC50 8x10-10 M)
[45]
|
compound 5d [PMID: 31335136]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
9.1
|
pIC50 |
51 |
|
⤷ |
pIC50
9.1
(IC50 8.7x10-10 M)
[51]
|
gilmelisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
>9.0
|
pIC50 |
79 |
|
⤷ |
pIC50
>9.0
(IC50 <1x10-9 M)
[79]
|
PIK-75
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.2 – 9.5
|
pIC50 |
37,48 |
|
⤷ |
pIC50
9.5
(IC50 3x10-10 M)
[37]
pIC50
8.2
(IC50 5.8x10-9 M)
[48]
|
PI-103
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.7
|
pIC50 |
68 |
|
⤷ |
pIC50
8.7
(IC50 2x10-9 M)
[68]
|
GSK1059615
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.7
|
pIC50 |
47 |
|
⤷ |
pIC50
8.7
(IC50 2x10-9 M)
[47]
|
paxalisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.7
|
pIC50 |
38 |
|
⤷ |
pIC50
8.7
(IC50 2x10-9 M)
[38]
|
panulisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.7
|
pIC50 |
42 |
|
⤷ |
pIC50
8.7
(IC50 2.2x10-9 M)
[42]
Description: Using a radiometric protein kinase (33PanQinase activity) assay.
|
pictilisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.5
|
pIC50 |
27 |
|
⤷ |
pIC50
8.5
(IC50 3x10-9 M)
[27]
|
dactolisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.4
|
pIC50 |
55 |
|
⤷ |
pIC50
8.4
(IC50 4x10-9 M)
[55]
|
BGT-226
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.4
|
pIC50 |
56 |
|
⤷ |
pIC50
8.4
(IC50 4x10-9 M)
[56]
|
KU-0060648
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.4
|
pIC50 |
13 |
|
⤷ |
pIC50
8.4
(IC50 4x10-9 M)
[13]
|
compound 27 [PMID: 35834807]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.4
|
pIC50 |
40 |
|
⤷ |
pIC50
8.4
(IC50 4.4x10-9 M)
[40]
|
apitolisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.3
|
pIC50 |
71 |
|
⤷ |
pIC50
8.3
(IC50 4.8x10-9 M)
[71]
|
alpelisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.3
|
pIC50 |
30 |
|
⤷ |
pIC50
8.3
(IC50 5x10-9 M)
[30]
|
risovalisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.2
|
pIC50 |
81 |
|
⤷ |
pIC50
8.2
(IC50 5.9x10-9 M)
[81]
|
AZD8835
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.2
|
pIC50 |
4 |
|
⤷ |
pIC50
8.2
(IC50 6.2x10-9 M)
[4]
|
samotolisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
8.2
|
pIC50 |
3 |
|
⤷ |
pIC50
8.2
(IC50 6.1x10-9 M)
[3]
|
NVP-CLR457
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.9
|
pIC50 |
26 |
|
⤷ |
pIC50
7.9
(IC50 1.2x10-8 M)
[26]
|
izorlisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.8
|
pIC50 |
61 |
|
⤷ |
pIC50
7.8
(IC50 1.4x10-8 M)
[61]
|
DS-7423
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.8
|
pIC50 |
43 |
|
⤷ |
pIC50
7.8
(IC50 1.56x10-8 M)
[43]
|
ZSTK474
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.8
|
pIC50 |
80 |
|
⤷ |
pIC50
7.8
(IC50 1.6x10-8 M)
[80]
|
VS-5584
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.8
|
pIC50 |
36 |
|
⤷ |
pIC50
7.8
(IC50 1.6x10-8 M)
[36]
|
XRD-0394
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.8
|
pIC50 |
29 |
|
⤷ |
pIC50
7.8
(IC50 1.6x10-8 M)
[29]
|
fimepinostat
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.7
|
pIC50 |
66 |
|
⤷ |
pIC50
7.7
(IC50 1.9x10-8 M)
[66]
|
buparlisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.5
|
pIC50 |
10 |
|
⤷ |
pIC50
7.5
(IC50 3x10-8 M)
[10]
|
AZD8186
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.5
|
pIC50 |
35 |
|
⤷ |
pIC50
7.5
(IC50 3.5x10-8 M)
[35]
|
pilaralisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.4
|
pIC50 |
80 |
|
⤷ |
pIC50
7.4
(IC50 3.9x10-8 M)
[80]
|
PP121
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.3
|
pIC50 |
2 |
|
⤷ |
pIC50
7.3
(IC50 5.2x10-8 M)
[2]
|
AZD8154
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.3
|
pIC50 |
64 |
|
⤷ |
pIC50
7.3
(IC50 5.5x10-8 M)
[64]
|
PI 3-Kg inhibitor
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.2
|
pIC50 |
11 |
|
⤷ |
pIC50
7.2
(IC50 6x10-8 M)
[11]
|
compound 11j [PMID: 23021994]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.0
|
pIC50 |
33 |
|
⤷ |
pIC50
7.0
(IC50 9.2x10-8 M)
[33]
|
serabelisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
>7.0
|
pIC50 |
69 |
|
⤷ |
pIC50
>7.0
(IC50 <1x10-7 M)
[69]
|
AZD7648
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
7.0
|
pIC50 |
32 |
|
⤷ |
pIC50
7.0
(IC50 1x10-7 M)
[32]
|
RV1729
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.7
|
pIC50 |
46 |
|
⤷ |
pIC50
6.7
(IC50 1.93x10-7 M)
[46]
Description: In a biochemical enzyme activity assay.
|
LY 294002
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.7
|
pIC50 |
13,18 |
|
⤷ |
pIC50
6.7
(IC50 3x10-7 – 2x10-7 M)
[13,18]
|
sapanisertib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.7
|
pIC50 |
41 |
|
⤷ |
pIC50
6.7
(IC50 2.19x10-7 M)
[41]
|
leniolisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.6
|
pIC50 |
20 |
|
⤷ |
pIC50
6.6
(IC50 2.62x10-7 M)
[20]
Description: In vitro enzyme assay
|
compound 2q [PMID: 30986068]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.6
|
pIC50 |
57 |
|
⤷ |
pIC50
6.6
(IC50 2.7x10-7 M)
[57]
Description: In a biochemical HTRF assay measuring generation of PIP3 via phosphorylation of PIP2, using PI3Kα 14-602 fragment.
|
dezapelisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
<6.3
|
pIC50 |
50 |
|
⤷ |
pIC50
<6.3
(IC50 >5x10-7 M)
[50]
|
zandelisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
<6.3
|
pIC50 |
8 |
|
⤷ |
pIC50
<6.3
(IC50 >5x10-7 M)
[8]
|
idelalisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.1
|
pIC50 |
49 |
|
⤷ |
pIC50
6.1
(IC50 8.2x10-7 M)
[49]
|
AZD6482
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.1
|
pIC50 |
60 |
|
⤷ |
pIC50
6.1
(IC50 8.7x10-7 M)
[60]
|
AS-252424
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.0
|
pIC50 |
65 |
|
⤷ |
pIC50
6.0
(IC50 9.35x10-7 M)
[65]
|
eCF309
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.0
|
pIC50 |
28 |
|
⤷ |
pIC50
6.0
(IC50 9.81x10-7 M)
[28]
Description: In a biochemical assay.
|
puquitinib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
6.0
|
pIC50 |
82 |
|
⤷ |
pIC50
6.0
(IC50 9.928x10-7 M)
[82]
|
compound 52 [PMID: 28541707]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.9
|
pIC50 |
54 |
|
⤷ |
pIC50
5.9
(IC50 1.19x10-6 M)
[54]
Description: Calculated based on 700-fold lower than affinity for PI3Kδ.
|
TG-100-115
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.9
|
pIC50 |
62 |
|
⤷ |
pIC50
5.9
(IC50 1.3x10-6 M)
[62]
|
SAR260301
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.8
|
pIC50 |
15 |
|
⤷ |
pIC50
5.8
(IC50 1.539x10-6 M)
[15]
|
duvelisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.8
|
pIC50 |
77 |
|
⤷ |
pIC50
5.8
(IC50 1.602x10-6 M)
[77]
|
compound 41 [PMID: 31855425]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.8
|
pIC50 |
39 |
|
⤷ |
pIC50
5.8
(IC50 1.585x10-6 M)
[39]
|
compound 7 [PMID: 31955578]
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.7
|
pIC50 |
5 |
|
⤷ |
pIC50
5.7
(IC50 2.2x10-6 M)
[5]
|
seletalisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.4
|
pIC50 |
1 |
|
⤷ |
pIC50
5.4
(IC50 3.638x10-6 M)
[1]
|
AZ2
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.4
|
pIC50 |
31 |
|
⤷ |
pIC50
5.4
(IC50 3.981x10-6 M)
[31]
|
PI 3-Kg inhibitor II
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.3
|
pIC50 |
11 |
|
⤷ |
pIC50
5.3
(IC50 4.5x10-6 M)
[11]
|
nemiralisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.3
|
pIC50 |
24 |
|
⤷ |
pIC50
5.3
(IC50 5.011x10-6 M)
[24]
Description: In a homogeneous time-resolved fluorescence (HTRF) assay
|
acalisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.3
|
pIC50 |
70 |
|
⤷ |
pIC50
5.3
(IC50 5.441x10-6 M)
[70]
Description: In an in vitro biochemical assay using recombinant enzyme.
|
AZD3458
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
5.1
|
pIC50 |
63 |
|
⤷ |
pIC50
5.1
(IC50 7.943x10-6 M)
[63]
Description: In a biochemical enzyme activity assay.
|
tenalisib
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
<5.0
|
pIC50 |
73 |
|
⤷ |
pIC50
<5.0
(IC50 >1x10-5 M)
[73]
Description: In a high throughput biochemical assay.
|
RV6153
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
<4.9
|
pIC50 |
72 |
|
⤷ |
pIC50
<4.9
(IC50 >1.39x10-5 M)
[72]
Description: In a biochemical enzyme activity assay.
|
quinostatin
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
4.8
|
pIC50 |
83 |
|
⤷ |
pIC50
4.8
(IC50 1.5x10-5 M)
[83]
Description: Inhibition of lipid-kinase activity in vitro.
|
AMG319
|
|
|
|
|
|
|
|
|
|
|
Hs |
Inhibition
|
4.5
|
pIC50 |
21 |
|
⤷ |
pIC50
4.5
(IC50 3.3x10-5 M)
[21]
|